NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $125 | +11.6% | 17,307 | +14.6% | 0.00% | – |
Q2 2023 | $112 | +21.7% | 15,106 | +13.6% | 0.00% | – |
Q1 2023 | $92 | -32.4% | 13,297 | -0.1% | 0.00% | – |
Q4 2022 | $136 | -99.9% | 13,312 | +15.7% | 0.00% | -100.0% |
Q3 2022 | $209,000 | -69.2% | 11,508 | -12.9% | 0.00% | -50.0% |
Q2 2022 | $679,000 | -17.4% | 13,211 | +18.4% | 0.00% | 0.0% |
Q1 2022 | $822,000 | -55.0% | 11,161 | -12.6% | 0.00% | -50.0% |
Q4 2021 | $1,826,000 | -30.0% | 12,764 | +1.4% | 0.00% | -42.9% |
Q3 2021 | $2,610,000 | +24.9% | 12,593 | +27.9% | 0.01% | +40.0% |
Q2 2021 | $2,090,000 | +19.7% | 9,847 | +2.2% | 0.01% | 0.0% |
Q1 2021 | $1,746,000 | +22.9% | 9,634 | -24.4% | 0.01% | +25.0% |
Q4 2020 | $1,421,000 | -15.1% | 12,751 | -17.5% | 0.00% | -33.3% |
Q3 2020 | $1,674,000 | +103.4% | 15,454 | +56.5% | 0.01% | +100.0% |
Q2 2020 | $823,000 | +315.7% | 9,877 | -32.3% | 0.00% | +200.0% |
Q1 2020 | $198,000 | +273.6% | 14,587 | +9.3% | 0.00% | – |
Q4 2019 | $53,000 | – | 13,351 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |